NCT01786863

Terminated

Frequency of Residual Neuromuscular Blockade in the Pediatri...

Nationwide Children's Hospital Source

ClinicalTrials.gov

Compare

Other study identifiers

Sponsor study identifier

IRB13-00045

Study Type

observational

Actual enrollment (reported)

5

Locations

1 country

Sites

1

Timeline

Study Start

February 2013

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

December 2015

Actual (reported)

Study Completion

December 2015

Actual (reported)

Brief Summary

This study is designed to investigate the frequency of Residual Neuromuscular Blockade (RNMB) in the pediatric population.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: terminated
Actual enrollment (reported): 5 participants
Study completion date: December 2015
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
February 2013
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
February 6, 2013
Actual (reported)
First Posted
February 8, 2013
Actual (reported)
Primary Completion
December 2015
Actual (reported)
Study Completion
December 2015
Actual (reported)

Last Updated: December 2, 2016
Status Verified: November 2016
Last Update Submitted: November 30, 2016

Conditions

Neuromuscular Blockade

Outcome Measures

Primary Outcomes (1)

train-of-four (TOF) ratio
TOF ratio shows the residual of neuromuscular agents.
1 day

Study Arms (1)

Neuromuscular blockade

Procedure: Neuromuscular blockade

Interventions

Neuromuscular blockadeProcedure

Neuromuscular blockade

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

AgeUp to 17 Years

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17)

Sampling MethodNon-Probability Sample

Study Population

Patients undergoing surgery that requires them to be paralyzed

You may qualify if:

Age less than 18 years.

Sponsors & Collaborators

Nationwide Children's Hospital
Otherlead

Study Sites (1)

Nationwide Children's

Columbus, Ohio, 43205, United States

MeSH Terms

Interventions

Neuromuscular Blockade

Intervention Hierarchy (Ancestors)

Anesthesia and AnalgesiaInvestigative Techniques

Enrollment

5 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Research Fellow

Study Record Dates

First Submitted

February 6, 2013

First Posted

February 8, 2013

Study Start

February 2013

Date type not reported

This date has not been verified as actual or estimated.

NCT02925143

Improving Neuromuscular Monitoring and Reducing Residual Neuromuscular Blockade Via E-learning

Not ApplicableCompleted

NCT04609410

Bleeding in Laparoscopic Liver Surgery

Not ApplicableTerminated

NCT02914119

Use of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals

Completed

NCT02513693

Deep Neuromuscular Blockade During Robotic Radical Prostatectomy

Phase 4Unknown

NCT05006807

Comparison Neuromuscular Blockade Monitors

Completed

NCT03168308

Sugammadex vs. Neostigmine for Neuromuscular Blockade Reversal in Thoracic Surgical Patients

Phase 4Completed

Surgery requiring the administration of neuromuscular blocking, agents with planned extubation in the postoperative care unit (PACU).

You may not qualify if:

Neuromuscular diseases which may prolong the duration of NMBA's or exaggerate the effects of residual blockade.
The need for postoperative mechanical ventilation.
Direct admission to the Pediatric ICU, NICU or CTICU.

Contact the study team to confirm eligibility.

Primary Completion

December 2015

Actual (reported)

Study Completion

December 2015

Actual (reported)

Last Updated

December 2, 2016

Record last verified: 2016-11

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT01786863
Data provider: ClinicalTrials.gov
Source updated: 2016-12-02
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:24:30 UTC

Locations

US(1)

Study Stopped

Frequency of Residual Neuromuscular Blockade in the Pediatric Population

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

Neuromuscular blockade

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

Neuromuscular blockade

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations